25 Jul

Angiolite BTK, below the knee sirolimus-eluting stent, receives CE Mark Approval

iVascular announces the release of Angiolite BTK, a sirolimus-eluting stent which has received CE Mark Approval for treating chronic and acute arterial lesions in lower limbs below the knee (BTK), improving blood flow in severe claudication and critical limb ischaemia.

Angiolite BTK design has been specifically elaborated for drug eluting stent and benefits from iVascular proprietary coating nanotechnology that yields a multilayer thin coating with optimal kinetics.

“Having the right bail-out options, when performing BTK angioplasty, is extremely important in saving limbs” claims Dr. Peter Goverde (Vascular Surgeon in ZNA Stuivenberg Hospital) “The latest generation DES, like the dedicated Angiolite BTK, can give you a solution and improve the outcome of your treatment.”

The first results of the clinical study led by Dr. Goverde, demonstrated a 6-month primary patency rate of 90% and an amelioration in wound healing and reduction of major amputation.

“With this new launch, iVascular is proud to offer a complete portfolio for the treatment of endovascular pathologies” – said Lluis Duocastella, CEO of iVascular.

Share this
13 May

iVascular at EuroPCR 2017

iVascular will be exhibiting at EuroPCR 2017 in Paris from May 16th to 19th. We invite you to visit our booth at Level 1 – F9 to know more about the company, innovations and technology we use creating our products.

The latest updates of the on-going clinical trials will be presented during the Scientific Sessions.

iVascular Scientific Activities at EuroPCR 2017 Programme:

  • Presentation:
Wednesday 17th ǀ ROOM MAILLOT, Level 2 Hot Line / LBT
New DES and DES comparisons
10:30 A randomized trial comparing sirolimus-eluting angiolite stents with everolimus-eluting Xience stents in patients with PCI.

J. Moreu Burgos

 

 
  • Abstracts/e-posters:
E-posters will be displayed at EuroPCR for the entire duration of the Course on touchscreens, in a dedicated friendly area
  -Preliminary results of real-life use of the latest generation of balloon expandable DES in below-the-knee treatment. Goverde P., Helsloot L., Taeymans K., Lauwers K., Verbuggen P., Vascular Clinic ZNA, Antwerp, Belgium

 

New processes in manufacturing, stent design and post-production control can improve clinical stent outcome. Goverde P., Helsloot L., Taeymans K., Lauwers K., Verbuggen P., Vascular Clinic ZNA, Antwerp, Belgium

 

 

Share this
03 Apr

iVascular Receives CE Mark Approval for iVolution 200mm SX stent

iVascular is pleased to announce the product range extension of its self-expandable stent iVolution, to 200 mm length, in various diameters.

iVolution is a last generation nitinol endovascular stent, combining high flexibility and conformability, together with increased radial strength. Its mechanical properties have been independently evaluated by the Paris Institute of Technology.

As stated by Lluis Duocastella, iVascular CEO, ” the addition of the 200mm iVolution to the iVascular portfolio, is a major step to improve patients therapy in the most complex indications such as TASC C and D femoro-popliteal lesions. We are excited to provide such new references to physicians, without any compromise on the French size compatibility, stent features nor ease of use”.

Share this
20 Mar

Capturer 7F has just received CE mark

iVascular has obtained CE mark for the thrombus extraction catheter Capturer 7F.

Capturer 7F has outstanding extraction capacity and claims to have the highest aspiration speed capability on the market. It is compatible with standard 0,014’’ guidewires, and is indicated for the manual extraction of fresh, soft thrombi from coronary and peripheral vasculature.

Capturer 7F is an addition to the existing range of iVascular, already including the Capturer 6F.

“We are excited about this new product to our portfolio,” – said Lluis Duocastella, CEO of iVascular. “Capturer 7F is the first of several new products that will join, in 2017, the range of products iVascular is offering. We are continuously looking forward to further support cardiovascular specialists in patients’ therapy.”

Share this
15 Mar

iVascular activities at SITE Symposium 2017

iVascular will be present at next coming SITE 2017, from March 29th to 31st in Barcelona, Spain.
This international event, organized by Prof. Vicente Riambau, is gathering KOLs from various countries, that will discuss hot topics in endovascular therapies.

For the preliminary agenda please follow the link

Do not miss those two presentations on March 30th. demonstrating Luminor and Angiolite key benefits!

    • Case in the Box 3 – March 30th, 9.00-9.30: “DCB therapy: the solution for popliteal bifurcation?” by Dr Roberto Ferraresi (Gavazzeni Hospital, Bergamo, Italy)
    • Case in the Box 4 – March 30th, 17.15-17.30: “Angiolite, a new DES to solve  BTK issues” by Dr Peter Goverde (Az Stuivenberg Antwerpen, Antwerp, Belgium)
Share this
20 Feb

LUMINOR Registry may help “reopen the door” for drug-coated balloons below the knee

Dr. Vicente Riambau (Autonomous University of Barcelona, Barcelona, Spain) presented LUMINOR REGISTRY 12 month follow-up at LINC-2017 and spoke to Vascular News about the results, TransferTech technology and future plans of the clinical program.

LUMINOR REGISTRY is an observational, prospective and multicentre study with single-arm treatment for native stenotic or occlusive lesions or in-stent stenosis of the femoro-poplietal (FP) and below the knee (BTK) vessels.


To watch the full interview please follow the link

Share this
25 Jan

iVascular Official Program Activities at LINC 2017

iVascular is pleased to announce that we will be exhibiting at LINC-2017 in Leipzig, January 24-27. We will be showcasing last updates of the on-going studies such as EFFFPAC with Luminor 35, LUMINOR REGISTRY and EVOLUTION at 6 months with self-expanded stent iVolution.

Please visit us at booth #17b.

We invite you to attend iVascular Official Program Activities:

  • Presentations:
Tuesday 24th ǀ Room 6- Speakers’ corner
13:05 – 13:10 LUMINOR registry: a real world experience with a new DEB in advanced limb ischemia V. Riambau
14:05 – 14:10 EffPac trial: Assessment of the effectiveness of DCB versus POBA in the SFA U. Teichgräber
14:20 – 14:25 First 6-month results in 75 patients in the EVOLUTION study: investigating the iVolution stent in femoropopliteal lesions M. Bosiers
Wednesday 25th ǀ Room 5- Global Expert Exchange Forum
10:58 – 11:04 New manufacturing process and stent design are key elements to improve clinical outcome. The iVascular example P. Goverde

 

  • Live cases:
Wednesday 25th ǀ Room 5- Global Expert Exchange Forum
08:00 – 10:10 Deep dive session: Lower limb interventions (part I) – aortoiliac, femoropopliteal, and new technologies for crossing and vessel preparation.

Moderators: C. Walker, K. Urasawa

Panel: M. Montero-Baker

Wednesday 25th ǀ Room 1- Main Arena 1
16:30 – 18:10 New concepts for complex femoropopliteal disease

Moderators: M. Bosiers, T. Ohki

Panel: S. Steiner, D. Choi, R. Langhoff, A. Micari, J. McKinsey, O. Iida

LINC is an interdisciplinary live course, designed to provide a global platform, permitting the discussion of the „vascular patients” by integrating colleagues of different specialties who are performing endovascular interventions.

Share this
18 Jan

iVascular will take part in AsiaPCR/SingLIVE 2017 in Singapore.

iVascular will take part in AsiaPCR/SingLIVE 2017, held on 19-21 January 2017 in Singapore.

We invite you to visit us at booth #15 to know more about our new product NC xperience.

 We encourage you to attend the presentation of Dr. Simon Lo “PCI with the Angiolite DES: an OCT study, the ANCHOR trial” on 19th of January at 2.12pm at Room 2.

course_en_asia

AsiaPCR/SingLIVE is an interactive educational course focusing on interventional cardiology in the Asia-Pacific region.

Share this
17 Jan

iVascular will be exhibiting at CACVS-2017 in Paris, France

iVascular is pleased to announce that we will be exhibiting at the international interactive post graduate course – Controversies and Updates in Vascular Surgery (CACVS) for Vascular Surgeons, Cardiac Surgeons, Vascular Radiologists and Angiologists.

CACVS-2017 will be held from January 19th to 21st in Paris, France.

iVascular official program activities:

 19th of January from 14:30, ePoster presentation “New manufacturing process and stent design are key elements to improve clinical outcome. The iVascular SX stent example” by Dr Peter Goverde will be available at the exhibition hall.

21st of January at 16:31, Prof. Riambau will speak about LUMINOR REGISTRY: Changing the paradigm of DCB in BTK: encouraging new results in complex lesions (AUDITORIUM / LEVEL -1).

We look forward to seeing you at the booth #14.

Share this
16 Nov

iVascular announces today that NC Xperience – non-compliant dilatation catheter – has received CE mark approval.

The NC Xperience catheter is now fully available in Europe and other countries that recognize the CE mark.

NC Xperience is indicated for:

  • CTOs and calcified lesions, requiring high pressure inflations and optimized crossing profile
  • Stent post-dilatation for enhance stent apposition to the artery wall.

“The non-compliant NC Xperience catheter is on the edge of the coronary balloon technology, providing the best combination of low crossing profile with high rated burst pressure (RBP),” commented Lluis Duocastella, CEO of iVascular S.L.U. “With this last addition to our portfolio, iVascular is now providing a complete platform to most demanding interventional cardiologists, performing highly complex interventions”.

The NC Xperience catheter offers an extra-low profile, outstanding deliverability and trackability, together with high pressure compatibility . It is available in a wide range of balloon diameters from 2.00 mm up to 5.0 mm, with balloon lengths ranging from 6 mm up to 30 mm.

iVascular is a fast-growing company based in Barcelona that has developed exclusive technologies in a vertically integrated project to innovate and produce coronary and endovascular devices from basic raw materials to the final device or implant, including DCB, DES, SE nitinol stents, CoCr BMS, thrombus extractors and angioplasty balloons.

Share this

© 2015 iVascular SLU. All rights reserved. Legal Notice | Terms of use Developed by Aprop Marketing

We use cookies to guarantee the best experience in your navigation. If you continue browsing consider to accept the use of cookies. More information

ACEPTAR
Aviso de cookies